Quick Links

Seattle COVID-Cohort Study at the VTU

Seattle COVID-Cohort Study at the VTU

This study will assess the immune responses to SARS-CoV-2/COVID-19 in three different groups. The body fights infection by producing different types of white blood cells that defend against foreign substances like viruses and bacteria. This process is called an immune response. The immune system responds in different ways that are not well understood. People experience different symptoms from SARS-CoV-2 infection. Different symptoms or the severity of COVID-19 may be due to differences in the immune system. We hope that by closely following the body’s specific immune responses in people who have had COVID-19, people who become infected and people who remain negative even after possible exposure, we can better understand which responses may be required for a successful vaccine or treatment against SARS-CoV-2/COVID-19.

To join a COVID study: https://redcap.link/COVID19-cohort
For more information: fredhutch.org/covid-cohort

Participant Eligibility

Over 18 years old
Not pregnant
Able to provide consent for the study
Phone screening to determine eligibility
At risk for COVID (COVID-negative)
Provide positive test result — for diagnosed COVID positive volunteers
Visit to one of the study sites


Kim Louis
(206) 667-7510

Additional Study Details

Full Study Title
Seattle COVID-19 Cohort Study to Evaluate Immune Responses in Persons at Risk and with SARS-CoV-2 Infection

Study ID: 10440
Start Date: 04/08/2020
End Date: 12/31/2021

M. Juliana McElrath, MD, PhD

Accepts Healthy Volunteers?

Study Site(s)

Cabrini Tower (First Hill)

901 Boren Ave #1320
Seattle, Washington 98104

Fred Hutch (Eastlake)

1100 Fairview Ave N
Seattle Washington 98119


Use the link below to send a message to the study coordinator, or call the number above to speak directly with a study representative.

I am interested in this research study.